Alembic Pharma Q4 FY25: Profit Slips 12% Despite Strong Revenue Growth   Alembic Pharmaceuticals Ltd., one of India’s established pharmaceutical companies, announced its financial results for the fourth quarter of the fiscal year 2024–25 (Q4 FY25), showcasing a mixed performance. … Continue reading Alembic Pharma Q4 FY25: Profit Slips 12% Despite Strong Revenue Growth